AntiCancer Japan Inc. - Research on Cancer Cell Visualization
AntiCancer Inc. (headquartered in the United States) is a biotech venture founded in 1984 in San Diego, California, by Robert M. Hoffman, a professor at the University of California, San Diego School of Medicine, aimed at the research, development, and sales of anti-cancer drugs and diagnostic agents. The company has 38 employees, of which 20 hold doctoral degrees or are medical doctors. While it has traditionally emphasized its activities in Japan, considering the future potential of the biotechnology and pharmaceutical market in Japan, it established AntiCancer Japan, Inc. on November 27, 2006. In April 2007, it built a P2 level research facility in Ibaraki City, Osaka Prefecture. The lab conducts research and development using its unique technology of in vivo imaging with small animals utilizing fluorescent proteins (green fluorescent protein (GFP) and red fluorescent protein (RFP)), and showcases small animal models. For more details, please contact us or download the catalog.
Inquire About This Product
basic information
**Main Technology Introduction** ○MetaMouse → The only human cancer metastasis model mouse that faithfully reflects the symptoms of human cancer patients. ○HDRA (Histoculture Drug Response Assay) → A method to determine the optimal anticancer drug for each cancer patient in vitro. ○Methioninase(R) (Methionine-degrading enzyme) and PEG-Methioninase → A method of cancer treatment that lowers the concentration of methionine in the blood using methionine-degrading enzymes and combines it with other anticancer drugs to kill cancer cells. ○OncoBrite (GFP/RFP-MetaMouse & AngioMouse) → A collective term for technologies using fluorescent proteins such as GFP-MetaMouse, AngioMouse, cancer cells labeled with GFP or RFP, and fluorescence imaging devices. ○Hyase (Homocysteine Measurement Kit) → A kit that specifically measures only homocysteine in the blood using a recombinant enzyme (homocysteinase). ○DermaTek ○Cancer treatment using bacteria ● For more details, please contact us or download the catalog.
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please contact us or download the catalog.
catalog(1)
Download All CatalogsCompany information
AntiCancer Inc., headquartered in the United States, was founded in 1984 in San Diego, California, by Robert M. Hoffman, a professor at the University of California, San Diego School of Medicine. It is a biotech venture focused on the research, development, and sales of anticancer drugs and diagnostic agents. Considering the future potential of the biotechnology and pharmaceutical market in Japan, AntiCancer Japan Co., Ltd. was established on November 27, 2006. In April 2007, a P2 level research facility was constructed in Ibaraki City, Osaka Prefecture. A lab was opened for the research and development of in vivo imaging using its proprietary technology, which includes fluorescent proteins (green fluorescent protein (GFP) and red fluorescent protein (RFP)), as well as the exhibition of small animal models. Currently, the company primarily supports cancer research for its clients using fluorescent imaging technology.